Russell Investments Group Ltd. Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Russell Investments Group Ltd. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 79.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 627,105 shares of the company’s stock after acquiring an additional 278,097 shares during the quarter. Russell Investments Group Ltd.’s holdings in GE HealthCare Technologies were worth $47,095,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the third quarter worth $26,000. E Fund Management Hong Kong Co. Ltd. boosted its position in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares in the last quarter. Allianz SE boosted its position in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares in the last quarter. Oakworth Capital Inc. grew its stake in GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after buying an additional 394 shares during the last quarter. Finally, Piscataqua Savings Bank grew its stake in GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after buying an additional 300 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Stifel Nicolaus increased their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, February 4th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price objective for the company from $73.00 to $77.00 in a report on Thursday, January 15th. Jefferies Financial Group increased their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Finally, Citigroup lowered their target price on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research note on Wednesday. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $92.17.

GE HealthCare Technologies Stock Down 0.1%

GEHC stock opened at $72.65 on Thursday. The company has a market capitalization of $33.11 billion, a P/E ratio of 15.93, a price-to-earnings-growth ratio of 1.60 and a beta of 1.03. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77. The firm’s fifty day simple moving average is $81.26 and its 200-day simple moving average is $78.57. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.